The PI3K, AKT, ERK, and mTOR prosurvival mediators are important therapeutic targets, as they are constitutively activated in many cancers and contribute to cancer progression by promoting cellular proliferation and inhibiting cell death signalling pathways (Falasca, 2010). This evidence concerns the gene AKT1 and cancer.